aluates Reports

$ 0.0

Automative

Global Surgical Fibrin Formulation Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-34B7121

Global Surgical Fibrin Formulation Market Insights Forecast to 2028

BUY CHAPTERS

Global Surgical Fibrin Formulation Market Insights, Forecast to 2030

Code: QYRE-Auto-34B7121

Report

December 2024

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Baxter International

CSL Behring

Johnson & Johnson

LifeBond

Pharming Group

Sea Run

Shanghai Raas

Tissuemed

Surgical Fibrin Formulation Market Size

The global Surgical Fibrin Formulation market is projected to grow from US$ 1256 million in 2024 to US$ 2286.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.5% during the forecast period.

Surgical Fibrin Formulation Market

Surgical Fibrin Formulation is a surgical formulation used to create a fibrin clot for hemostasis, cartilage repair surgeries or wound healing.

Market Analysis and Insights: Global Surgical Fibrin Formulation Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Covers:

This report presents an overview of global market for Surgical Fibrin Formulation market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Surgical Fibrin Formulation, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Surgical Fibrin Formulation, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Surgical Fibrin Formulation revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Surgical Fibrin Formulation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Surgical Fibrin Formulation revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Surgical Fibrin Formulation Market Report

Report Metric	Details
Report Name	Surgical Fibrin Formulation Market
Accounted market size in 2024	US$ 1256 in million
Forecasted market size in 2030	US$ 2286.5 million
CAGR	10.5
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Natural Synthetic
Segment by Application	Hospital Clinic and Emergency Room Nursing Home Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Baxter International, CSL Behring, Johnson & Johnson, LifeBond, Pharming Group, Sea Run, Shanghai RAAS, Tissuemed
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Surgical Fibrin Formulation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Surgical Fibrin Formulation companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Surgical Fibrin Formulation revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Surgical Fibrin Formulation Market growing?

Ans: The Surgical Fibrin Formulation Market witnessing a CAGR of 10.5 during the forecast period 2025-2030.

What is the Surgical Fibrin Formulation Market size in 2030?

Ans: The Surgical Fibrin Formulation Market size in 2030 will be US$ 2286.5 million.

Who are the main players in the Surgical Fibrin Formulation Market report?

Ans: The main players in the Surgical Fibrin Formulation Market are Baxter International, CSL Behring, Johnson & Johnson, LifeBond, Pharming Group, Sea Run, Shanghai RAAS, Tissuemed

What are the Application segmentation covered in the Surgical Fibrin Formulation Market report?

Ans: The Applications covered in the Surgical Fibrin Formulation Market report are Hospital, Clinic and Emergency Room, Nursing Home, Others

What are the Type segmentation covered in the Surgical Fibrin Formulation Market report?

Ans: The Types covered in the Surgical Fibrin Formulation Market report are Natural, Synthetic

Recommended Reports

Surgical Wound Care

Hemostats and Sealants

Fibrin and Blood Products

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Surgical Fibrin Formulation Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Natural

1.2.3 Synthetic

1.3 Market by Application

1.3.1 Global Surgical Fibrin Formulation Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic and Emergency Room

1.3.4 Nursing Home

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Surgical Fibrin Formulation Market Perspective (2019-2030)

2.2 Global Surgical Fibrin Formulation Growth Trends by Region

2.2.1 Surgical Fibrin Formulation Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Surgical Fibrin Formulation Historic Market Size by Region (2019-2024)

2.2.3 Surgical Fibrin Formulation Forecasted Market Size by Region (2025-2030)

2.3 Surgical Fibrin Formulation Market Dynamics

2.3.1 Surgical Fibrin Formulation Industry Trends

2.3.2 Surgical Fibrin Formulation Market Drivers

2.3.3 Surgical Fibrin Formulation Market Challenges

2.3.4 Surgical Fibrin Formulation Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Surgical Fibrin Formulation by Players

3.1.1 Global Surgical Fibrin Formulation Revenue by Players (2019-2024)

3.1.2 Global Surgical Fibrin Formulation Revenue Market Share by Players (2019-2024)

3.2 Global Surgical Fibrin Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Surgical Fibrin Formulation, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Surgical Fibrin Formulation Market Concentration Ratio

3.4.1 Global Surgical Fibrin Formulation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Surgical Fibrin Formulation Revenue in 2023

3.5 Global Key Players of Surgical Fibrin Formulation Head office and Area Served

3.6 Global Key Players of Surgical Fibrin Formulation, Product and Application

3.7 Global Key Players of Surgical Fibrin Formulation, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Surgical Fibrin Formulation Breakdown Data by Type

4.1 Global Surgical Fibrin Formulation Historic Market Size by Type (2019-2024)

4.2 Global Surgical Fibrin Formulation Forecasted Market Size by Type (2025-2030)

5 Surgical Fibrin Formulation Breakdown Data by Application

5.1 Global Surgical Fibrin Formulation Historic Market Size by Application (2019-2024)

5.2 Global Surgical Fibrin Formulation Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Surgical Fibrin Formulation Market Size (2019-2030)

6.2 North America Surgical Fibrin Formulation Market Size by Type

6.2.1 North America Surgical Fibrin Formulation Market Size by Type (2019-2024)

6.2.2 North America Surgical Fibrin Formulation Market Size by Type (2025-2030)

6.2.3 North America Surgical Fibrin Formulation Market Share by Type (2019-2030)

6.3 North America Surgical Fibrin Formulation Market Size by Application

6.3.1 North America Surgical Fibrin Formulation Market Size by Application (2019-2024)

6.3.2 North America Surgical Fibrin Formulation Market Size by Application (2025-2030)

6.3.3 North America Surgical Fibrin Formulation Market Share by Application (2019-2030)

6.4 North America Surgical Fibrin Formulation Market Size by Country

6.4.1 North America Surgical Fibrin Formulation Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Surgical Fibrin Formulation Market Size by Country (2019-2024)

6.4.3 North America Surgical Fibrin Formulation Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Surgical Fibrin Formulation Market Size (2019-2030)

7.2 Europe Surgical Fibrin Formulation Market Size by Type

7.2.1 Europe Surgical Fibrin Formulation Market Size by Type (2019-2024)

7.2.2 Europe Surgical Fibrin Formulation Market Size by Type (2025-2030)

7.2.3 Europe Surgical Fibrin Formulation Market Share by Type (2019-2030)

7.3 Europe Surgical Fibrin Formulation Market Size by Application

7.3.1 Europe Surgical Fibrin Formulation Market Size by Application (2019-2024)

7.3.2 Europe Surgical Fibrin Formulation Market Size by Application (2025-2030)

7.3.3 Europe Surgical Fibrin Formulation Market Share by Application (2019-2030)

7.4 Europe Surgical Fibrin Formulation Market Size by Country

7.4.1 Europe Surgical Fibrin Formulation Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Surgical Fibrin Formulation Market Size by Country (2019-2024)

7.4.3 Europe Surgical Fibrin Formulation Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Surgical Fibrin Formulation Market Size (2019-2030)

8.2 China Surgical Fibrin Formulation Market Size by Type

8.2.1 China Surgical Fibrin Formulation Market Size by Type (2019-2024)

8.2.2 China Surgical Fibrin Formulation Market Size by Type (2025-2030)

8.2.3 China Surgical Fibrin Formulation Market Share by Type (2019-2030)

8.3 China Surgical Fibrin Formulation Market Size by Application

8.3.1 China Surgical Fibrin Formulation Market Size by Application (2019-2024)

8.3.2 China Surgical Fibrin Formulation Market Size by Application (2025-2030)

8.3.3 China Surgical Fibrin Formulation Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Surgical Fibrin Formulation Market Size (2019-2030)

9.2 Asia Surgical Fibrin Formulation Market Size by Type

9.2.1 Asia Surgical Fibrin Formulation Market Size by Type (2019-2024)

9.2.2 Asia Surgical Fibrin Formulation Market Size by Type (2025-2030)

9.2.3 Asia Surgical Fibrin Formulation Market Share by Type (2019-2030)

9.3 Asia Surgical Fibrin Formulation Market Size by Application

9.3.1 Asia Surgical Fibrin Formulation Market Size by Application (2019-2024)

9.3.2 Asia Surgical Fibrin Formulation Market Size by Application (2025-2030)

9.3.3 Asia Surgical Fibrin Formulation Market Share by Application (2019-2030)

9.4 Asia Surgical Fibrin Formulation Market Size by Region

9.4.1 Asia Surgical Fibrin Formulation Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Surgical Fibrin Formulation Market Size by Region (2019-2024)

9.4.3 Asia Surgical Fibrin Formulation Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Type

10.2.1 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Application

10.3.1 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Country

10.4.1 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Baxter International

11.1.1 Baxter International Company Details

11.1.2 Baxter International Business Overview

11.1.3 Baxter International Surgical Fibrin Formulation Introduction

11.1.4 Baxter International Revenue in Surgical Fibrin Formulation Business (2019-2024)

11.1.5 Baxter International Recent Developments

11.2 CSL Behring

11.2.1 CSL Behring Company Details

11.2.2 CSL Behring Business Overview

11.2.3 CSL Behring Surgical Fibrin Formulation Introduction

11.2.4 CSL Behring Revenue in Surgical Fibrin Formulation Business (2019-2024)

11.2.5 CSL Behring Recent Developments

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Surgical Fibrin Formulation Introduction

11.3.4 Johnson & Johnson Revenue in Surgical Fibrin Formulation Business (2019-2024)

11.3.5 Johnson & Johnson Recent Developments

11.4 LifeBond

11.4.1 LifeBond Company Details

11.4.2 LifeBond Business Overview

11.4.3 LifeBond Surgical Fibrin Formulation Introduction

11.4.4 LifeBond Revenue in Surgical Fibrin Formulation Business (2019-2024)

11.4.5 LifeBond Recent Developments

11.5 Pharming Group

11.5.1 Pharming Group Company Details

11.5.2 Pharming Group Business Overview

11.5.3 Pharming Group Surgical Fibrin Formulation Introduction

11.5.4 Pharming Group Revenue in Surgical Fibrin Formulation Business (2019-2024)

11.5.5 Pharming Group Recent Developments

11.6 Sea Run

11.6.1 Sea Run Company Details

11.6.2 Sea Run Business Overview

11.6.3 Sea Run Surgical Fibrin Formulation Introduction

11.6.4 Sea Run Revenue in Surgical Fibrin Formulation Business (2019-2024)

11.6.5 Sea Run Recent Developments

11.7 Shanghai RAAS

11.7.1 Shanghai RAAS Company Details

11.7.2 Shanghai RAAS Business Overview

11.7.3 Shanghai RAAS Surgical Fibrin Formulation Introduction

11.7.4 Shanghai RAAS Revenue in Surgical Fibrin Formulation Business (2019-2024)

11.7.5 Shanghai RAAS Recent Developments

11.8 Tissuemed

11.8.1 Tissuemed Company Details

11.8.2 Tissuemed Business Overview

11.8.3 Tissuemed Surgical Fibrin Formulation Introduction

11.8.4 Tissuemed Revenue in Surgical Fibrin Formulation Business (2019-2024)

11.8.5 Tissuemed Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Baxter International

CSL Behring

Johnson & Johnson

LifeBond

Pharming Group

Sea Run

Shanghai Raas

Tissuemed

List of Tables

Table 1. Global Surgical Fibrin Formulation Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Natural

Table 3. Key Players of Synthetic

Table 4. Global Surgical Fibrin Formulation Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Surgical Fibrin Formulation Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Surgical Fibrin Formulation Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Surgical Fibrin Formulation Market Share by Region (2019-2024)

Table 8. Global Surgical Fibrin Formulation Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Surgical Fibrin Formulation Market Share by Region (2025-2030)

Table 10. Surgical Fibrin Formulation Market Trends

Table 11. Surgical Fibrin Formulation Market Drivers

Table 12. Surgical Fibrin Formulation Market Challenges

Table 13. Surgical Fibrin Formulation Market Restraints

Table 14. Global Surgical Fibrin Formulation Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Surgical Fibrin Formulation Revenue Share by Players (2019-2024)

Table 16. Global Top Surgical Fibrin Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Fibrin Formulation as of 2023)

Table 17. Global Surgical Fibrin Formulation Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Surgical Fibrin Formulation Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Surgical Fibrin Formulation, Headquarters and Area Served

Table 20. Global Key Players of Surgical Fibrin Formulation, Product and Application

Table 21. Global Key Players of Surgical Fibrin Formulation, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Surgical Fibrin Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Surgical Fibrin Formulation Revenue Market Share by Type (2019-2024)

Table 25. Global Surgical Fibrin Formulation Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Surgical Fibrin Formulation Revenue Market Share by Type (2025-2030)

Table 27. Global Surgical Fibrin Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Surgical Fibrin Formulation Revenue Share by Application (2019-2024)

Table 29. Global Surgical Fibrin Formulation Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Surgical Fibrin Formulation Revenue Share by Application (2025-2030)

Table 31. North America Surgical Fibrin Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Surgical Fibrin Formulation Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Surgical Fibrin Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Surgical Fibrin Formulation Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Surgical Fibrin Formulation Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Surgical Fibrin Formulation Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Surgical Fibrin Formulation Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Surgical Fibrin Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Surgical Fibrin Formulation Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Surgical Fibrin Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Surgical Fibrin Formulation Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Surgical Fibrin Formulation Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Surgical Fibrin Formulation Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Surgical Fibrin Formulation Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Surgical Fibrin Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Surgical Fibrin Formulation Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Surgical Fibrin Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Surgical Fibrin Formulation Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Surgical Fibrin Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Surgical Fibrin Formulation Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Surgical Fibrin Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Surgical Fibrin Formulation Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Surgical Fibrin Formulation Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Surgical Fibrin Formulation Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Surgical Fibrin Formulation Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Surgical Fibrin Formulation Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size by Country (2025-2030) & (US$ Million)

Table 63. Baxter International Company Details

Table 64. Baxter International Business Overview

Table 65. Baxter International Surgical Fibrin Formulation Product

Table 66. Baxter International Revenue in Surgical Fibrin Formulation Business (2019-2024) & (US$ Million)

Table 67. Baxter International Recent Developments

Table 68. CSL Behring Company Details

Table 69. CSL Behring Business Overview

Table 70. CSL Behring Surgical Fibrin Formulation Product

Table 71. CSL Behring Revenue in Surgical Fibrin Formulation Business (2019-2024) & (US$ Million)

Table 72. CSL Behring Recent Developments

Table 73. Johnson & Johnson Company Details

Table 74. Johnson & Johnson Business Overview

Table 75. Johnson & Johnson Surgical Fibrin Formulation Product

Table 76. Johnson & Johnson Revenue in Surgical Fibrin Formulation Business (2019-2024) & (US$ Million)

Table 77. Johnson & Johnson Recent Developments

Table 78. LifeBond Company Details

Table 79. LifeBond Business Overview

Table 80. LifeBond Surgical Fibrin Formulation Product

Table 81. LifeBond Revenue in Surgical Fibrin Formulation Business (2019-2024) & (US$ Million)

Table 82. LifeBond Recent Developments

Table 83. Pharming Group Company Details

Table 84. Pharming Group Business Overview

Table 85. Pharming Group Surgical Fibrin Formulation Product

Table 86. Pharming Group Revenue in Surgical Fibrin Formulation Business (2019-2024) & (US$ Million)

Table 87. Pharming Group Recent Developments

Table 88. Sea Run Company Details

Table 89. Sea Run Business Overview

Table 90. Sea Run Surgical Fibrin Formulation Product

Table 91. Sea Run Revenue in Surgical Fibrin Formulation Business (2019-2024) & (US$ Million)

Table 92. Sea Run Recent Developments

Table 93. Shanghai RAAS Company Details

Table 94. Shanghai RAAS Business Overview

Table 95. Shanghai RAAS Surgical Fibrin Formulation Product

Table 96. Shanghai RAAS Revenue in Surgical Fibrin Formulation Business (2019-2024) & (US$ Million)

Table 97. Shanghai RAAS Recent Developments

Table 98. Tissuemed Company Details

Table 99. Tissuemed Business Overview

Table 100. Tissuemed Surgical Fibrin Formulation Product

Table 101. Tissuemed Revenue in Surgical Fibrin Formulation Business (2019-2024) & (US$ Million)

Table 102. Tissuemed Recent Developments

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Surgical Fibrin Formulation Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Surgical Fibrin Formulation Market Share by Type: 2023 VS 2030

Figure 3. Natural Features

Figure 4. Synthetic Features

Figure 5. Global Surgical Fibrin Formulation Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Surgical Fibrin Formulation Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Clinic and Emergency Room Case Studies

Figure 9. Nursing Home Case Studies

Figure 10. Others Case Studies

Figure 11. Surgical Fibrin Formulation Report Years Considered

Figure 12. Global Surgical Fibrin Formulation Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Surgical Fibrin Formulation Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Surgical Fibrin Formulation Market Share by Region: 2023 VS 2030

Figure 15. Global Surgical Fibrin Formulation Market Share by Players in 2023

Figure 16. Global Top Surgical Fibrin Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Fibrin Formulation as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Surgical Fibrin Formulation Revenue in 2023

Figure 18. North America Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Surgical Fibrin Formulation Market Share by Type (2019-2030)

Figure 20. North America Surgical Fibrin Formulation Market Share by Application (2019-2030)

Figure 21. North America Surgical Fibrin Formulation Market Share by Country (2019-2030)

Figure 22. United States Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Surgical Fibrin Formulation Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Surgical Fibrin Formulation Market Share by Type (2019-2030)

Figure 26. Europe Surgical Fibrin Formulation Market Share by Application (2019-2030)

Figure 27. Europe Surgical Fibrin Formulation Market Share by Country (2019-2030)

Figure 28. Germany Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Surgical Fibrin Formulation Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Surgical Fibrin Formulation Market Share by Type (2019-2030)

Figure 36. China Surgical Fibrin Formulation Market Share by Application (2019-2030)

Figure 37. Asia Surgical Fibrin Formulation Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Surgical Fibrin Formulation Market Share by Type (2019-2030)

Figure 39. Asia Surgical Fibrin Formulation Market Share by Application (2019-2030)

Figure 40. Asia Surgical Fibrin Formulation Market Share by Region (2019-2030)

Figure 41. Japan Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Surgical Fibrin Formulation Market Share by Country (2019-2030)

Figure 51. Brazil Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Surgical Fibrin Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Baxter International Revenue Growth Rate in Surgical Fibrin Formulation Business (2019-2024)

Figure 58. CSL Behring Revenue Growth Rate in Surgical Fibrin Formulation Business (2019-2024)

Figure 59. Johnson & Johnson Revenue Growth Rate in Surgical Fibrin Formulation Business (2019-2024)

Figure 60. LifeBond Revenue Growth Rate in Surgical Fibrin Formulation Business (2019-2024)

Figure 61. Pharming Group Revenue Growth Rate in Surgical Fibrin Formulation Business (2019-2024)

Figure 62. Sea Run Revenue Growth Rate in Surgical Fibrin Formulation Business (2019-2024)

Figure 63. Shanghai RAAS Revenue Growth Rate in Surgical Fibrin Formulation Business (2019-2024)

Figure 64. Tissuemed Revenue Growth Rate in Surgical Fibrin Formulation Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Fibrin Surgical Sealant and Adhesive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Fibrin Glue Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Surgical Hemostatic Material Market Research Report 2025

Medical Fibrin Sealant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Fibrin Glue Hemostat Market Research Report 2024

Wound Closure Surgical Products Market

Surgical Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Fibrin Sealant Product Market Research Report 2024

Global Human and Porcine Fibrin Sealant Market Research Report 2025

Hemostatic Gel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Fibrin Adhesive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Surgical Adhesives and Sealants Market Research Report 2024

Absorbable Surgical Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global General Surgery Hemostatic Agents Market Research Report 2024

Surgical Absorbable Hemostatic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Liquid Fibrin Sealants Market Research Report 2024

Surgical Topical Absorbable Hemostat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Wound Surgery Hemostatic Agents Market Research Report 2024

Surgical Skin Glue Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions